English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Jose A. Sintas, Norberto J. Macareno and Arturo A. VitalePROPLAME-CONICET, Departamento de Quimica Organica, Facultad de Ciencias Exactas y Natu-rales, Universidad de Buenos Aires, Pabellon 2, Ciudad Universitaria, 1428 Buenos Aires, ArgentinaThe resurgence of interest in Boron Neutron Capture Therapy (BNCT) as a treatment for malignantlesions has resulted in the synthesis of numerous boron compounds as candidates for clinical use.BNCT is a selective radiotherapy using boron-10 which absorbs thermal neutrons and releases highLinear Energy Transfer (LET) alpha particles by

A Facile High-Yield Synthesis of [10 B]-8-Dihydroxyboryl Harmine, a Potential Agent for Boron Neutron Capture Therapy